Latest filing published 06 Apr 2026 for Cartesian Therapeutics, Inc.. Read the official filing
No signal scores available.
This profile gathers the share dealings of Elizabeth Hoge in Cartesian Therapeutics, Inc. Over a trading history stretching from 8 April 2024 to 2 April 2026, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 6 April 2026, reports an option exercise in Cartesian Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations